Applications including "European Pharmacopoeia"
-
LT195 - Eighteenth revision Japanese Pharmacopoeia analysis of tranexamic acid -2.00 Condition change within the range specified in the general chromatography- -
LC Technical Note InertSustain AQ-C18 -
GT146 - Japanese Pharmacopoeia, 18th Edition Analysis of Saccharin Sodium Hydrate - 2.00 Change of Conditions Specified within General Theory of Chromatography -
GC Technical Note -
GT145 - Japanese Pharmacopoeia, 18th Edition Analysis of Macrogol 400 - 2.00 Change of Conditions Specified within General Theory of Chromatography -
GC Technical Note -
LB698 - Analysis of Neomycin Sulfate (European Pharmacopoeia 11.0th Edition, Purity Test) -
LC InertSearch InertSustain C18 -
LB660 - Analysis of Copovidone(Under the Condition of European Pharmacopoeia 10.0, Impurity A) -
LC InertSearch Inertsil ODS-4 -
LT147 - D-Mannitol Analysis Under USP Method -
LC Technical Note InertSphere Sugar-2 HAMILTON HC-75(Ca2+) -
LT131 - HPLC Columns Compliant with Pharmacopoeia (USP, EP and JP) -
LC Technical Note -
LB370 - Analysis of Prednisolone (Under the Condition of European Pharmacopoeia 8.2) -
LC InertSearch Inertsil ODS-3 -
LB279 - Analysis of Indometacin (Under the Condition of European Pharmacopoeia 8.2) -
LC InertSearch InertSustain Phenylhexyl -
LB082 - Analysis of Sertraline hydrochloride (Under the Condition of European Pharmacopoeia 7.0) -
LC InertSearch Inertsil ODS-3 -
GA245 - Analysis of Sertraline Hydrochloride(Under the Condition of European Pharmacopoeia 7.0) -
GC InertSearch InertCap 17